PCM
SSKN

Perritt Capital Management’s Strata Skin Sciences SSKN Stock Holding History

Perritt Capital Management’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed -$30.7K – 323
2024
Q2 		$30.7K Hold
10,000
– – 0.02% 241
2024
Q1 		$37.8K Hold
10,000
– – 0.02% 235
2023
Q4 		$55K Hold
10,000
– – 0.03% 216
2023
Q3 		$59.5K Hold
10,000
– – 0.03% 209
2023
Q2 		$95K Buy
10,000
+2,925
+41% +$28.8K 0.05% 199
2023
Q1 		$74.9K Hold
7,075
– – 0.04% 208
2022
Q4 		$55.9K Buy
+7,075
New +$60.7K 0.03% 222

Other funds holding SSKN

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAM
Azzad Asset Management Falls Church, Virginia $989M AUM 27.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perritt Capital Management's SSKN Position: Q3 2024 in Review

Perritt Capital Management sold out of Strata Skin Sciences (SSKN) in Q3 2024, closing a stake of 10,000 shares — an estimated $30.7K sold.

Perritt Capital Management first reported a position in SSKN in Q4 2022 and held it in 7 quarters. The position peaked at $95K in Q2 2023. 19 funds tracked by Wall St. Rank hold SSKN as of Q3 2024.

  • Perritt Capital Management reported no remaining Strata Skin Sciences position as of Q3 2024 after selling out during the quarter.
  • Perritt Capital Management sold 10,000 Strata Skin Sciences shares in Q3 2024, an estimated $30.7K.
  • Perritt Capital Management first reported a position in Strata Skin Sciences in Q4 2022 and held it in 7 quarters.
  • Perritt Capital Management's Strata Skin Sciences position peaked at $95K in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q3 2024.

Based on Perritt Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.